Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
McKinsey
Merck
Farmers Insurance
Mallinckrodt
McKesson

Generated: June 17, 2019

DrugPatentWatch Database Preview

Litigation Details for In Re: Bristol-Meyers Squibb Co. Securities Litigation (S.D.N.Y. 2007)

« Back to Dashboard

Small Molecule Drugs cited in In Re: Bristol-Meyers Squibb Co. Securities Litigation
The small molecule drugs covered by the patents cited in this case are ➤ Sign Up , ➤ Sign Up , and ➤ Sign Up .
Biologic Drugs cited in In Re: Bristol-Meyers Squibb Co. Securities Litigation
The biologic drug covered by the patents cited in this case is ➤ Sign Up .

Details for In Re: Bristol-Meyers Squibb Co. Securities Litigation (S.D.N.Y. 2007)

Date Filed Document No. Description Snippet Link To Document
2007-11-12 32 Exhibit Q-Y to LLReisner Declaration in Support of Motion to Dismiss CLAIMS 1,2,8, 11 AND 12 of U.S. Patent 4,529,596. Document filed by Apotex Inc…Construction of Claims 1,2,8,11 and 12 of U.S. Patent No. 4,529,596 (Apotex Motion…Sanofi/BMS against Apotex over U.S Patent No. 4,847,265 (the '265 patent) that had been scheduled for June…challenging its patents. At the time of the ANDA's approval, Apotex was in the midst of patent litigation…Plavix doesn't infringe on the drug patent because the patent is invalid. But if a court finds External link to document
2008-01-07 41 Reply Affirmation in Support of Motion litigations between them involving U.S. Patent No. 4,847,265, 02CV−2255 and 05CV−3965, on the following… litigations between them involving U.S. Patent No. 4,847,265, 02CV−2255 and 05CV−3965, on the following…composition of matter patent covering ABILIFY* (U.S. Patent No. 5,006,528, the ‘582 Patent). In June 2006, …a composition of a matter patent for clopidogrel bisulfate (the ‘265 Patent), a medicine made available…damages under applicable patent laws if they were to prevail in the pending patent litigation. The companies External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cantor Fitzgerald
Julphar
Chinese Patent Office
Harvard Business School
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.